The Photosensitising Clinical Agent Verteporfin Is an Inhibitor of SPAK and OSR1 Kinases. - AlAmri MA; Kadri H; Alderwick LJ; Jeeves M; Mehellou Y (Chembiochem : a European journal of chemical biology, 2018)